(Q43864894)

27 November 2017

title

High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma (English)

1 reference

27 November 2017

1 reference

4

Henrik Gronberg

1 reference

27 November 2017

Katarina Shahedi

1

1 reference

27 November 2017

Monica Emanuelsson

series ordinal

2

1 reference

27 November 2017

Fredrik Wiklund

series ordinal

3

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

27 November 2017

1 reference

27 November 2017

volume

106

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

1237-1242

1 reference

Clinical and histological predictors of contralateral breast cancer.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

Contralateral breast cancer: clinical characteristics and impact on prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

Contralateral breast cancer: annual incidence and risk parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

Prognostic factors for metachronous contralateral breast cancer: a comparison of the linear Cox regression model and its artificial neural network extension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

Cancer risks in BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

Evolving perspectives in contralateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

‘Arimidex’ (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer-efficacy overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

Familial breast cancer: an investigation into the outcome of treatment for early stage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

Risk factors and age-incidence relationships for contralateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

7 January 2021

Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

7 January 2021

Contralateral breast cancer and other second malignancies in patients treated by breast-conserving therapy with radiation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

7 January 2021

Clinical epidemiology of bilateral breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

7 January 2021

Risk factors for contralateral breast cancer in Chennai (Madras), India

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

7 January 2021

Risk of contralateral breast cancer in Denmark 1943-80.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

7 January 2021

Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

7 January 2021

Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). XI. Bilateral breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

7 January 2021

Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

7 January 2021

Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

7 January 2021

Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

7 January 2021

One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

7 January 2021

Second primary cancers of the breast: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

7 January 2021

Risk of contralateral breast cancer: associations with factors related to initial breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21753

7 January 2021

Identifiers

DOI

10.1002/CNCR.21753

1 reference

27 November 2017

1 reference